QUICK ANSWER · AEO / GEO
An SSRI approved for adult major depressive disorder in the reviewed U.S. label; premature-ejaculation evidence remains off-label, with QT prolongation and medicine-interaction risks requiring a separate assessment.
ENTITY FACTS
What should readers identify first?
What remains unknown?
English translation is not yet verified for 3 excerpt(s). This is a language gap, not an absence of risks or uncertainty.
Read original excerpts (Thai / mixed language)
- หลักฐาน PE ไม่เปลี่ยน citalopram ให้เป็นยาที่อนุมัติสำหรับ PE โดยอัตโนมัติ
- Citalopram ไม่ใช่ escitalopram แม้เกี่ยวข้องกันทางเคมี และไม่ควรถ่ายโอนทะเบียน ข้อบ่งใช้ หรือฉลากระหว่างกัน
- ผลต่อการหลั่งไม่ใช่หลักฐานรักษาภาวะหย่อนสมรรถภาพทางเพศ เพิ่มความต้องการ หรือเพิ่มความพึงพอใจในทุกคน
What limits these conclusions?
Insufficient data in the current dataset
This overview does not replace the detailed adverse-event and product-specific risk discussion in the complete Thai profile or the original sources.
EVIDENCE BOUNDARY
What this overview does not establish
- An evidence grade does not rank this molecule against another treatment.
- A molecule name does not establish the identity, purity or regulatory status of a product.
- Animal, cell or biomarker findings do not automatically establish human clinical benefit.
- Approval in one country or indication does not transfer globally.
Where can I check the evidence?
Original sources from the same evidence record used by Compare. Read each source's population, methods, limitations and date; a citation is not product endorsement.
FAQ · ANSWER ENGINE
Frequently asked questions
What is Citalopram?
Citalopram is described pharmacologically as Selective serotonin reuptake inhibitor (SSRI). An SSRI approved for adult major depressive disorder in the reviewed U.S. label; premature-ejaculation evidence remains off-label, with QT prolongation and medicine-interaction risks requiring a separate assessment.
Does Citalopram have strong evidence?
PrimeCoreBio records Evidence Grade A. This grade describes evidence strength, not comparative effectiveness or suitability for an individual.
Is Citalopram approved everywhere?
No global conclusion should be inferred. PrimeCore Class A must be read with the exact product, country and indication on the source-rich profile.
Educational information only. This page does not provide diagnosis, treatment, prescribing, dosage, injection instructions or individual medical advice.